儿科住院医生的适应性 针对国际病联盟 - - 2017年发作分类与模块化教育计划
Muharrem İmanli1, Erdem Şimşek2, Afshin Dezhakam2
1Department of Pediatrics, Ege University Children's Hospital, İzmir, Turkey.
Turkish archives of pediatrics
|September 6, 2023
概括
儿科住院医生在模块化教育计划后显示了41%的成功率,适应了国际病联盟2017年发作分类. 需要进一步培训才能有效地在临床上应用ILAE-2017指南.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 医学教育 医学教育
背景情况:
- 国际抗联盟 (ILAE) 在2017年更新了其发作分类.
- 有效的实施需要临床医生,特别是儿科住院医生理解和准确地应用.
研究的目的:
- 评估儿科住院医生对ILAE-2017发作分类的初步适应能力.
- 评估模块化教育计划 (MEP) 在提高这种适应能力方面的有效性.
主要方法:
- 开发了一个由8个模块组成的MEP,其中5个模块专注于ILAE-2017和3个模块专注于较旧的ILAE-1981分类.
- 儿科住院医生完成了MEP,其中包括视频示例和决定器.
- 在3个月的随访后,进行了58个新视频的后测试.
主要成果:
- 对于ILAE-2017 (41%) 和ILAE-1981 (38.5%) 分类的总体成功率在MEP之后是相似的.
- 在ILAE-2017下,与焦点运动发作 (34.9%) 相比,在分类焦点非运动发作 (56.3%) 中观察到更高的准确性.
- 在 ILAE-2017 中,一般性非运动性 (26%) 与一般性运动性 (46%) 的准确性较低.
- 通常错误分类的发作类型包括自动性,肌性发作和非典型缺席.
结论:
- 一天的MEP在儿科住院人员中导致适应ILAE-2017发作分类的初步适应能力 (41%的成功率).
- 为了成功实施ILAE-2017分类的临床应用,需要进行额外的MEP提升会议.
更多相关视频
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
17.3K
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
9.4K
相关概念视频
01:13Seizures: Classification
408
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
408
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
341
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
341
01:20Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210
01:30Electroconvulsive Therapy
68
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
68